Cargando…
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Ewing sarcoma is the second most common solid bone malignancy diagnosed in pediatric and young adolescent populations. Despite global co-operative efforts, outcomes for patients with relapsed and refractory disease remains obstinately poor. It has become increasingly clear that disruption of the epi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284858/ https://www.ncbi.nlm.nih.gov/pubmed/30559927 http://dx.doi.org/10.18632/oncotarget.26326 |